Fundraising Fox
🦊/Companies
Sign in

Biosyntia

Copenhagen, DK · 2 known investors

Find your way into Biosyntia

Biosyntia is a Copenhagen-based industrial biotech company that uses strain engineering and fermentation to produce sustainable, bio-based active ingredients like vitamin B7, replacing petrochemical-derived alternatives for cosmetics and nutrition markets.

Investors · 2

European Circular Bioeconomy FundBonn · $5.5M – $16.5M
Sofinnova PartnersParis · $540K – $27M

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Biosyntia secures Series B funding for “world’s first” natural B-vitamin productionnutritioninsight.com · Oct 2022Danish biotech startup closes €11.5M Series B to introduce its natural and sustainably produced biotin - ArcticStartuparcticstartup.com · Jul 2022Biosyntia accelerates bio-based biotin production with €11.5m Series B funding roundnutraingredients.com · Jul 2022Biosyntia closes a €11.5m Series B round, backed by ECBF - Private Equity Wireprivateequitywire.co.uk · Jul 2022Biosyntia Raises €4M to Advance its Synthetic Biology Technologylabiotech.eu · May 2018Biosyntia closes 11.5 million EUR round to launch world’s first bio-based vitamin B7indianchemicalnews.com

Frequently asked questions

What does Biosyntia do?
Biosyntia is a Copenhagen-based industrial biotech company that uses strain engineering and fermentation to produce sustainable, bio-based active ingredients like vitamin B7, replacing petrochemical-derived alternatives for cosmetics and nutrition markets.
Who are Biosyntia's investors?
Biosyntia's investors include European Circular Bioeconomy Fund, Sofinnova Partners.
Where is Biosyntia headquartered?
Biosyntia is headquartered in Copenhagen, DK.